409 related articles for article (PubMed ID: 29083328)
1. Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review.
Jagadeesan AJ; Murugesan R; Vimala Devi S; Meera M; Madhumala G; Vishwanathan Padmaja M; Ramesh A; Banerjee A; Sushmitha S; Khokhlov AN; Marotta F; Pathak S
Acta Biomed; 2017 Oct; 88(3):249-262. PubMed ID: 29083328
[TBL] [Abstract][Full Text] [Related]
2. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis.
Bhat S; Acharya UR; Hagiwara Y; Dadmehr N; Adeli H
Comput Biol Med; 2018 Nov; 102():234-241. PubMed ID: 30253869
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
Bang Y; Lim J; Choi HJ
Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease: a review of non-motor symptoms.
Rana AQ; Ahmed US; Chaudry ZM; Vasan S
Expert Rev Neurother; 2015 May; 15(5):549-62. PubMed ID: 25936847
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence.
Bhidayasiri R; Truong DD
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S110-3. PubMed ID: 22166405
[TBL] [Abstract][Full Text] [Related]
7. Neurobiology of depression in Parkinson's disease: Insights into epidemiology, molecular mechanisms and treatment strategies.
Ahmad MH; Rizvi MA; Ali M; Mondal AC
Ageing Res Rev; 2023 Mar; 85():101840. PubMed ID: 36603690
[TBL] [Abstract][Full Text] [Related]
8. Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder.
Khan AU; Akram M; Daniyal M; Zainab R
Int J Neurosci; 2019 Jan; 129(1):55-93. PubMed ID: 29883227
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.
Fu R; Luo XG; Ren Y; He ZY; Lv H
Transl Neurodegener; 2016; 5():9. PubMed ID: 27175281
[TBL] [Abstract][Full Text] [Related]
10. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Meles SK; Oertel WH; Leenders KL
Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
[TBL] [Abstract][Full Text] [Related]
11. [Does early detection of non-motor symptoms facilitate early treatment of Parkinson's disease?].
Hasegawa K
Brain Nerve; 2012 Apr; 64(4):453-61. PubMed ID: 22481518
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.
Abou Kassm S; Naja W; Haddad R; Pelissolo A
Curr Psychiatry Rep; 2021 Mar; 23(4):20. PubMed ID: 33660146
[TBL] [Abstract][Full Text] [Related]
13. Anxiety in Parkinson's disease: a critical review of experimental and clinical studies.
Prediger RD; Matheus FC; Schwarzbold ML; Lima MM; Vital MA
Neuropharmacology; 2012 Jan; 62(1):115-24. PubMed ID: 21903105
[TBL] [Abstract][Full Text] [Related]
14. Translational molecular imaging and drug development in Parkinson's disease.
Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
[TBL] [Abstract][Full Text] [Related]
15. New horizons in Parkinson's disease in older populations.
Chhetri JK; Mei S; Wang C; Chan P
Age Ageing; 2023 Oct; 52(10):. PubMed ID: 37847793
[TBL] [Abstract][Full Text] [Related]
16. [The Diagnosis and Indication for Surgical Treatment in Parkinson's Disease].
Maruo T
No Shinkei Geka; 2021 Jul; 49(4):750-759. PubMed ID: 34376607
[TBL] [Abstract][Full Text] [Related]
17. [Neuropsychiatric manifestations in Parkinson's disease].
Oikonomou E; Paparrigopoulos T
Psychiatriki; 2015; 26(2):116-30. PubMed ID: 26197101
[TBL] [Abstract][Full Text] [Related]
18. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Smith KM; Eyal E; Weintraub D;
JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
20. [Syndrome of rapid eye movement sleep behavior disorder and nocturia in Parkinson's disease].
Nodel MR; Ukraintseva YV; Yakhno NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):15-20. PubMed ID: 29053115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
